These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 423204)

  • 21. Aterial blood pressure in dogs: effects of m-tyrosine alone or in combination with inhibitors of aromatic amino acid decarboxylase; relative hypotensive potencies of L-dopa, DL-m-tyrosine, and L-m-tyrosine.
    Minsker DH; Stokes AL
    Experientia; 1974 Sep; 30(9):1051-3. PubMed ID: 4412113
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies on dopa decarboxylase inhibitors in vivo by use of C14-carboxyl-labeled dopa.
    HANSSON E; CLARK WG
    Proc Soc Exp Biol Med; 1962 Dec; 111():793-8. PubMed ID: 13952652
    [No Abstract]   [Full Text] [Related]  

  • 23. Purification and characterization of rat-liver 3,4-dihydroxyphenylalanine decarboxylase.
    Dominici P; Tancini B; Barra D; Voltattorni CB
    Eur J Biochem; 1987 Nov; 169(1):209-13. PubMed ID: 3119338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical properties and kinetic parameters of dihydroxyphenylalanine--5-hydroxytryptophan decarboxylase in brain, liver, and adrenals of cat.
    Bouchard S; Roberge AG
    Can J Biochem; 1979 Jul; 57(7):1014-8. PubMed ID: 39668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of catechol-O-methyl transferase by L-dopa and decarboxylase inhibitors.
    Baldessarini RJ
    J Pharm Pharmacol; 1972 Jan; 24(1):78-80. PubMed ID: 4401326
    [No Abstract]   [Full Text] [Related]  

  • 26. The influence of L-DOPA perfusion concentrations and peripheral decarboxylase inhibition on dopa accumulation and decarboxylation in isolated perfused rat brains.
    Horst WD; Bautz G; Renyi E; Spirt N
    Neuropharmacology; 1973 Dec; 12(12):1145-51. PubMed ID: 4782694
    [No Abstract]   [Full Text] [Related]  

  • 27. Acid-base chemistry of the reaction of aromatic L-amino acid decarboxylase and dopa analyzed by transient and steady-state kinetics: preferential binding of the substrate with its amino group unprotonated.
    Hayashi H; Tsukiyama F; Ishii S; Mizuguchi H; Kagamiyama H
    Biochemistry; 1999 Nov; 38(47):15615-22. PubMed ID: 10569946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo studies on the conversion of m-tyrosine to 3,4-dihydroxyphenylalanine in the rat.
    Tong JH; Smyth RG; Benoiton NL; D'Iorio A
    Can J Biochem; 1977 Oct; 55(10):1103-7. PubMed ID: 912602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of aromatic L-amino acid decarboxylase under physiological conditions: optimization of 3-hydroxybenzylhydrazine concentration to prevent concurrent inhibition of monoamine oxidase.
    Hunter LW; Rorie DK; Tyce GM
    Biochem Pharmacol; 1993 Mar; 45(6):1363-6. PubMed ID: 8096696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DOPA decarboxylase inhibition through the interaction of coenzyme and substrate.
    SCHOTT HF; CLARK WG
    J Biol Chem; 1952 May; 196(1):449-62. PubMed ID: 12980987
    [No Abstract]   [Full Text] [Related]  

  • 31. alpha-difluoromethyl DOPA, a new enzyme-activated irreversible inhibitor of aromatic L-amino acid decarboxylase.
    Palfreyman MG; Danzin C; Bey P; Jung MJ; Ribereau-Gayon G; Aubry M; Vevert JP; Sjoerdsma A
    J Neurochem; 1978 Oct; 31(4):927-32. PubMed ID: 308998
    [No Abstract]   [Full Text] [Related]  

  • 32. Failure of vitamin B6 to reverse the L-dopa effect in patients on a dopa decarboxylase inhibitor.
    Klawans HL; Ringel SP; Shenker DM
    J Neurol Neurosurg Psychiatry; 1971 Dec; 34(6):682-6. PubMed ID: 5158783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of dopamine from L-3,4-dihydroxyphenylalanine by human amniotic epithelial cells.
    Elwan MA
    Eur J Pharmacol; 1998 Jul; 354(1):R1-2. PubMed ID: 9726639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homologs of dopa, alpha-methyldopa, and dopamine as potential cardiovascular drugs.
    Winn M; Rasmussen R; Minard F; Kyncl J; Plotnikoff N
    J Med Chem; 1975 Apr; 18(4):434-7. PubMed ID: 1079053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reactions of DOPA (3,4-dihydroxyphenylalanine) decarboxylase with DOPA.
    Minelli A; Charteris AT; Voltattorni CB; John RA
    Biochem J; 1979 Nov; 183(2):361-8. PubMed ID: 534502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rat liver aromatic L-amino acid decarboxylase: spectroscopic and kinetic analysis of the coenzyme and reaction intermediates.
    Hayashi H; Mizuguchi H; Kagamiyama H
    Biochemistry; 1993 Jan; 32(3):812-8. PubMed ID: 8422386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of catechol structure in the inhibitory effects of D-isomers of amino acids on the decarboxylation of L-5-hydroxytryptophan.
    Shikimi T; Inagaki C; Takaori S
    Experientia; 1978 Sep; 34(9):1188-9. PubMed ID: 309827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypothalamic secretion of dopamine after inhibition of aromatic L-amino acid decarboxylase activity.
    Reymond MJ; Porter JC
    Endocrinology; 1982 Oct; 111(4):1051-6. PubMed ID: 6811255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parkinsonian syndromes. Treatment by association of L-dopa plus decarboxylase inhibitor.
    Gauthier G; Juge O; Birchler A
    Eur Neurol; 1974; 11(3):133-57. PubMed ID: 4839098
    [No Abstract]   [Full Text] [Related]  

  • 40. Dopa decarboxylase activity of the living human brain.
    Gjedde A; Reith J; Dyve S; Léger G; Guttman M; Diksic M; Evans A; Kuwabara H
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2721-5. PubMed ID: 1688340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.